Department of Psychosis Studies, Institute of Psychiatry, King's College London, De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.
Institute of Mental Health, Jubilee Campus, University of Nottingham, Nottingham, UK.
Psychol Med. 2021 Sep;51(12):2074-2082. doi: 10.1017/S0033291720000847. Epub 2020 Apr 28.
First episode psychosis (FEP) patients who use cannabis experience more frequent psychotic and euphoric intoxication experiences compared to controls. It is not clear whether this is consequent to patients being more vulnerable to the effects of cannabis use or to their heavier pattern of use. We aimed to determine whether extent of use predicted psychotic-like and euphoric intoxication experiences in patients and controls and whether this differs between groups.
We analysed data on patients who had ever used cannabis ( = 655) and controls who had ever used cannabis ( = 654) across 15 sites from six countries in the EU-GEI study (2010-2015). We used multiple regression to model predictors of cannabis-induced experiences and to determine if there was an interaction between caseness and extent of use.
Caseness, frequency of cannabis use and money spent on cannabis predicted psychotic-like and euphoric experiences ( ⩽ 0.001). For psychotic-like experiences (PEs) there was a significant interaction for caseness × frequency of use ( < 0.001) and caseness × money spent on cannabis ( = 0.001) such that FEP patients had increased experiences at increased levels of use compared to controls. There was no significant interaction for euphoric experiences ( > 0.5).
FEP patients are particularly sensitive to increased psychotic-like, but not euphoric experiences, at higher levels of cannabis use compared to controls. This suggests a specific psychotomimetic response in FEP patients related to heavy cannabis use. Clinicians should enquire regarding cannabis related PEs and advise that lower levels of cannabis use are associated with less frequent PEs.
与对照组相比,首次出现精神病症状(FEP)的使用大麻的患者经历更多的精神病和欣快中毒体验。目前尚不清楚这是由于患者更容易受到大麻使用的影响,还是由于他们更重的使用模式。我们旨在确定使用程度是否可以预测患者和对照组的类精神病和欣快中毒体验,以及这种预测在两组之间是否存在差异。
我们分析了来自欧盟-基因研究(EU-GEI)的 15 个地点的 6 个国家中曾使用过大麻的患者(=655)和曾使用过大麻的对照组(=654)的数据(2010-2015 年)。我们使用多元回归来建立大麻引起的体验的预测因素模型,并确定病例状态和使用程度之间是否存在相互作用。
病例状态、大麻使用频率和用于购买大麻的钱数预测了类精神病体验和欣快体验( ⩽ 0.001)。对于类精神病体验(PEs),病例状态×使用频率( ⩽ 0.001)和病例状态×用于购买大麻的钱数( = 0.001)之间存在显著的相互作用,即与对照组相比,FEP 患者在更高的使用水平上会增加体验。对于欣快体验( > 0.5),则不存在显著的相互作用。
与对照组相比,FEP 患者在更高水平的大麻使用时,对增加的类精神病体验(但不是欣快体验)特别敏感。这表明 FEP 患者与大量大麻使用有关的特定类精神病反应。临床医生应该询问与大麻相关的 PEs 并建议,较低水平的大麻使用与较少的 PEs 相关。